Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity ...

A research team has developed an AI-based personalized cancer vaccine design technology that enables long-term immunity that ...

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).

Houston Methodist Research Institute is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) and leading scientific institutions in the Republic of Korea to develop what could ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

South Florida scientists are developing innovative ways to use RNA technology to destroy cancer cells, but uncertainty over ...

Bayer has filed patent infringement lawsuits against COVID-19 vaccine makers Pfizer, BioNTech, Moderna, and Johnson & Johnson ...

An update from Moderna ( (MRNA) ) is now available.

Bayer has filed lawsuits against major COVID-19 vaccine producers Pfizer, BioNTech, Moderna, and Johnson & Johnson for allegedly infringing on its mRNA technology patents, originally developed by ...